Cargando…
Incretin-Based Therapy and Risk of Pancreatic Cancer in Patients with Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Controlled Trials
INTRODUCTION: The present study aims to evaluate the risk of pancreatic cancer with incretin-based therapy among patients with type 2 diabetes mellitus (T2DM). METHODS: We searched EMBASE, MEDLINE, the Cochrane Central Register of Controlled Trials and ClinicalTrials.gov for eligible studies publish...
Autores principales: | Chen, Han, Zhou, Xiaoying, Chen, Tao, Liu, Bingtuan, Jin, Wujuan, Gu, Huiyuan, Hong, Tianyuan, Zhang, Guoxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118236/ https://www.ncbi.nlm.nih.gov/pubmed/27655330 http://dx.doi.org/10.1007/s13300-016-0198-3 |
Ejemplares similares
-
Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies
por: Li, Ling, et al.
Publicado: (2014) -
Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-Analysis
por: Chen, Han, et al.
Publicado: (2016) -
Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes
por: Ahn, Chang Ho, et al.
Publicado: (2023) -
Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
por: Schwartz, Stanley, et al.
Publicado: (2010) -
Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus
por: Nisal, Kaustubh, et al.
Publicado: (2012)